Elevated De Ritis Ratio Is Associated With Poor Prognosis in COVID-19: A Systematic Review and Meta-Analysis

Raymond Pranata1, Ian Huang1,2, Michael Anthonius Lim1

  • 1Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia.

Frontiers in Medicine
|January 10, 2022
PubMed

Insights

An elevated De Ritis ratio (AST/ALT) is linked to worse outcomes in COVID-19 patients. This finding suggests the ratio can help predict prognosis in coronavirus cases.

Area of Science:

  • Medical Diagnostics
  • Infectious Diseases
  • Biomarkers

Background:

  • The De Ritis ratio, or Aspartate aminotransferase/alanine transaminase (AST/ALT) ratio, is a potential indicator of liver function and cellular damage.
  • Its association with prognosis in coronavirus 2019 (COVID-19) patients requires comprehensive evaluation.

Approach:

  • A systematic literature review and meta-analysis was conducted using data from PubMed, Embase, and EuropePMC databases.
  • Eight studies encompassing 4,606 patients were analyzed to assess the relationship between elevated De Ritis ratio and COVID-19 prognosis.
  • Key outcomes included mortality, disease severity, ICU admission, and intubation, with statistical measures like odds ratios and mean differences calculated.

Key Points:

  • Elevated De Ritis ratio was observed in 44% of patients and was significantly higher in those with poor prognosis (mean difference 0.41) and non-survivors (mean difference 0.47).
  • An elevated De Ritis ratio was associated with poor COVID-19 prognosis (OR 3.28), demonstrating a sensitivity of 55% and specificity of 71%.
  • The posterior probability of poor prognosis was 38% with an elevated De Ritis ratio, compared to 17% when not elevated.

Conclusions:

  • The De Ritis ratio serves as a valuable biomarker for predicting poor prognosis in COVID-19 patients.
  • This meta-analysis confirms a significant association between an elevated AST/ALT ratio and adverse outcomes in coronavirus disease.
  • Further research may explore the clinical utility of the De Ritis ratio in managing COVID-19 patients.

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
483
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
103
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.7K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
29
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
678
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
284